{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:06:29Z","timestamp":1774382789920,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Brucellosis is regarded as one of the world\u2019s most severe zoonotic diseases. This study aimed to investigate the <jats:italic>p<\/jats:italic>ossibility of using recombinant <jats:italic>Lactococcus lactis<\/jats:italic> (<jats:italic>L. lactis<\/jats:italic>) as a live vector to produce recombinant <jats:italic>Brucella abortus<\/jats:italic> (<jats:italic>B. abortus<\/jats:italic>) <jats:italic>Omp10<\/jats:italic>. The gene sequences were obtained from GenBank. The proteins\u2019 immunogenicity was assessed using Vaxijen. After confirming the cloning of the <jats:italic>Omp10<\/jats:italic> gene in the pNZ8148 vector by enzymatic digestion and PCR, transformation into <jats:italic>L. lactis<\/jats:italic> was done. SDS-PAGE and western blot methods evaluated <jats:italic>omp10<\/jats:italic> protein expression. Mice received oral recombinant <jats:italic>L. lactis<\/jats:italic> vaccines. IgG antibodies against <jats:italic>Omp10<\/jats:italic> were tested using ELISA. Real-time PCR and ELISA were used to analyze cytokine responses. Survival rate and histopathological changes were evaluated after the challenge. <jats:italic>Omp10<\/jats:italic> was chosen for its 1.5524 antigenicity score. Enzymatic digestion and PCR identified a 381-bp gene fragment. A 10\u00a0kDa band indicated the success of <jats:italic>L. lactis<\/jats:italic> transformation. Mice administered the <jats:italic>L. lactis<\/jats:italic>-pNZ8148-<jats:italic>Omp<\/jats:italic>10-Usp45 vaccination 14\u00a0days after priming showed significantly higher <jats:italic>Omp10<\/jats:italic>-specific total IgG and IgG1 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) than the PBS control group. The mice who received the <jats:italic>L. lactis<\/jats:italic>-pNZ8148-<jats:italic>Omp10<\/jats:italic>-Usp45 and IRBA vaccines had significantly elevated levels of IFN-\u03b3, TNF\u03b1, IL-4, and IL-10 in samples collected on days 14 and 28 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Inflammatory response, morphological damage, alveolar edema, and lymphocyte infiltration were reduced in the target group. A recombinant <jats:italic>L. lactis<\/jats:italic> expressing the <jats:italic>Omp10<\/jats:italic> protein was constructed as an oral <jats:italic>Lactococcus<\/jats:italic>-based vaccine and compared to live attenuated vaccines for future brucellosis investigations.<\/jats:p>","DOI":"10.1186\/s13568-023-01638-4","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T15:02:29Z","timestamp":1704294149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design of an oral vaccine using Lactococcus lactis against brucellosis: an in vitro and in vivo study"],"prefix":"10.1186","volume":"14","author":[{"given":"Mahsa","family":"Kazemi-Roudsari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Doosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Saeid","family":"Jami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"11","key":"1638_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/pathogens9110942","volume":"9","author":"MG Bialer","year":"2020","unstructured":"Bialer MG, Sycz G, Mu\u00f1oz Gonz\u00e1lez F, Ferrero MC, Baldi PC, Zorreguieta A (2020) Adhesins of Brucella: their roles in the interaction with the host. Pathogens 9(11):942","journal-title":"Pathogens"},{"issue":"5","key":"1638_CR2","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/jam.14237","volume":"126","author":"E Bohlul","year":"2019","unstructured":"Bohlul E, Hasanlou F, Taromchi AH, Nadri S (2019) TRAIL-expressing recombinant Lactococcus lactis induces apoptosis in human colon adenocarcinoma SW480 and HCT116 cells. J Appl Microbiol 126(5):1558\u20131567","journal-title":"J Appl Microbiol"},{"key":"1638_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.903890","volume":"9","author":"A Darbandi","year":"2022","unstructured":"Darbandi A, Alamdary SZ, Koupaei M, Ghanavati R, Heidary M, Talebi M (2022) Evaluation of immune responses to Brucella vaccines in mouse models: a systematic review. Front Vet Sci 9:903890","journal-title":"Front Vet Sci"},{"issue":"2","key":"1638_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/vaccines8020146","volume":"8","author":"DA Diaz-Dinamarca","year":"2020","unstructured":"Diaz-Dinamarca DA, Hernandez C, Escobar DF, Soto DA, Mu\u00f1oz GA, Badilla JF, Manzo RA, Carri\u00f3n F, Kalergis AM, Vasquez AE (2020) Mucosal vaccination with Lactococcus lactis-secreting surface immunological protein induces humoral and cellular immune protection against group b Streptococcus in a murine model. Vaccines 8(2):146","journal-title":"Vaccines"},{"key":"1638_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-015-0199-7","volume":"46","author":"EM Dorneles","year":"2015","unstructured":"Dorneles EM, Sriranganathan N, Lage AP (2015) Recent advances in Brucella abortus vaccines. Vet Res 46:1\u201310","journal-title":"Vet Res"},{"key":"1638_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vetimm.2016.02.002","volume":"171","author":"MJ Ducrotoy","year":"2016","unstructured":"Ducrotoy MJ, Conde-\u00c1lvarez R, Blasco JM, Moriy\u00f3n I (2016) A review of the basis of the immunological diagnosis of ruminant brucellosis. Vet Immunol Immunopathol 171:81\u2013102","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"1638_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00203-023-03471-6","volume":"205","author":"Z Fatehi","year":"2023","unstructured":"Fatehi Z, Doosti A, Jami MS (2023) Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus. Arch Microbiol 205(4):122","journal-title":"Arch Microbiol"},{"key":"1638_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101552","volume":"72","author":"G Ghajari","year":"2021","unstructured":"Ghajari G, Nabiuni M, Amini E (2021) The association between testicular toxicity induced by Li2Co3 and protective effect of Ganoderma lucidum: alteration of Bax & c-Kit genes expression. Tissue Cell 72:101552","journal-title":"Tissue Cell"},{"key":"1638_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/vms3.1173","author":"ST Gouran","year":"2023","unstructured":"Gouran ST, Doosti A, Jami MS (2023) Brucella abortus antigen omp25 vaccines: development and targeting based on Lactococcus lactis. Vet Med Sci. https:\/\/doi.org\/10.1002\/vms3.1173","journal-title":"Vet Med Sci"},{"issue":"27","key":"1638_CR10","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","volume":"30","author":"VK Gupta","year":"2012","unstructured":"Gupta VK, Radhakrishnan G, Harms J, Splitter G (2012) Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis. Vaccine 30(27):4017\u20134022","journal-title":"Vaccine"},{"key":"1638_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.925773","volume":"9","author":"M Heidary","year":"2022","unstructured":"Heidary M, Dashtbin S, Ghanavati R, Mahdizade Ari M, Bostanghadiri N, Darbandi A, Navidifar T, Talebi M (2022) Evaluation of brucellosis vaccines: a comprehensive review. Front Vet Sci 9:925773","journal-title":"Front Vet Sci"},{"issue":"30","key":"1638_CR12","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","volume":"37","author":"H Hou","year":"2019","unstructured":"Hou H, Liu X, Peng Q (2019) The advances in brucellosis vaccines. Vaccine 37(30):3981\u20133988","journal-title":"Vaccine"},{"key":"1638_CR13","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1016\/j.apsb.2022.07.002","volume":"12","author":"M Huang","year":"2022","unstructured":"Huang M, Zhang M, Zhu H, Du X, Wang J (2022) Mucosal vaccine delivery: a focus on the breakthrough of specific barriers. Acta Pharm Sin B 12:3456\u20133474","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1638_CR14","doi-asserted-by":"publisher","first-page":"2110821","DOI":"10.1080\/19490976.2022.2110821","volume":"14","author":"R Levit","year":"2022","unstructured":"Levit R, Cortes-Perez NG, de Moreno de Leblanc A, Loiseau J, Aucouturier A, Langella P, LeBlanc JG, Berm\u00fadez-Humar\u00e1n LG (2022) Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health. Gut Microbes 14(1):2110821","journal-title":"Gut Microbes"},{"issue":"6","key":"1638_CR15","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/1751-7915.14015","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Wang S, Wei S, Yang G, Zhang C, Xi L, Zhang J, Cui Y, Hao J, Zhang H, Zhang H (2022) Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild-type challenge in BALB\/c mice. Microb Biotechnol 15(6):1811\u20131823","journal-title":"Microb Biotechnol"},{"issue":"4","key":"1638_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12223-021-00923-8","volume":"67","author":"X Liu","year":"2022","unstructured":"Liu X, Deng L, Li W, Zhong Z, Zhou Z, Peng G (2022) Construction of a recombinant food-grade Lactococcus lactis expressing P23 protein of Cryptosporidium parvum. Folia Microbiol 67(4):625\u2013631","journal-title":"Folia Microbiol"},{"key":"1638_CR17","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3389\/fimmu.2019.01759","volume":"10","author":"R L\u00f3pez-Santiago","year":"2019","unstructured":"L\u00f3pez-Santiago R, S\u00e1nchez-Arg\u00e1ez AB, De Alba-N\u00fa\u00f1ez LG, Baltierra-Uribe SL, Moreno-Lafont MC (2019) Immune response to mucosal Brucella infection. Front Immunol 10:1759","journal-title":"Front Immunol"},{"key":"1638_CR500","doi-asserted-by":"publisher","first-page":"105705","DOI":"10.1016\/j.prevetmed.2022.105705","volume":"206","author":"R Olsen","year":"2022","unstructured":"Olsen SC, Boggiatto PM (2022) Characterization of the duration of immunity of Brucella abortus RB51 vaccination in cattle after experimental challenge. Prev Vet Med 206:105705","journal-title":"Preventive Veterinary Med"},{"key":"1638_CR18","doi-asserted-by":"publisher","first-page":"1018165","DOI":"10.3389\/fmicb.2022.1018165","volume":"13","author":"DW Pascual","year":"2022","unstructured":"Pascual DW, Goodwin ZI, Bhagyaraj E, Hoffman C, Yang X (2022) Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis. Front Microbiol 13:1018165","journal-title":"Front Microbiol"},{"issue":"3","key":"1638_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","volume":"34","author":"SD Perkins","year":"2010","unstructured":"Perkins SD, Smither SJ, Atkins HS (2010) Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34(3):379\u2013394","journal-title":"FEMS Microbiol Rev"},{"issue":"8\u201310","key":"1638_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/10611860410001670035","volume":"11","author":"DS Pontes","year":"2003","unstructured":"Pontes DS, Dorella FA, Ribeiro LA, Miyoshi A, Loir YL, Gruss A, Oliveira SC, Langella P, Azevedo V (2003) Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7\/L12 antigen. J Drug Target 11(8\u201310):489\u2013493","journal-title":"J Drug Target"},{"issue":"7","key":"1638_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/09291016.2019.1613794","volume":"52","author":"Priyanka","year":"2021","unstructured":"Priyanka, Shringi BN, Choudhary OP, Kashyap SK (2021) Cytokines in brucellosis: biological rhythm at the interface of innate and adaptive immunity. Biol Rhythm Res 52(7):1031\u20131043","journal-title":"Biol Rhythm Res"},{"issue":"2","key":"1638_CR22","doi-asserted-by":"publisher","first-page":"20210026","DOI":"10.1002\/EXP.20210026","volume":"1","author":"N Qiao","year":"2021","unstructured":"Qiao N, Du G, Zhong X, Sun X (2021) Recombinant lactic acid bacteria as promising vectors for mucosal vaccination. Exploration 1(2):20210026","journal-title":"Exploration"},{"issue":"1","key":"1638_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1139\/cjm-2019-0261","volume":"66","author":"M Rezaei","year":"2020","unstructured":"Rezaei M, Rabbani Khorasgani M, Zarkesh Esfahani SH, Emamzadeh R, Abtahi H (2020) Production of Brucella melitensis Omp16 protein fused to the human interleukin 2 in Lactococcus lactis MG1363 toward developing a Lactococcus-based vaccine against brucellosis. Can J Microbiol 66(1):39\u201345","journal-title":"Can J Microbiol"},{"key":"1638_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.113172","volume":"500","author":"Z Sadeghi","year":"2022","unstructured":"Sadeghi Z, Fasihi-Ramandi M, Bouzari S (2022) Brucella antigens (BhuA, 7\u03b1-HSDH, FliC) in poly I: C adjuvant as potential vaccine candidates against brucellosis. J Immunol Methods 500:113172","journal-title":"J Immunol Methods"},{"issue":"7","key":"1638_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","volume":"30","author":"D S\u00e1ez","year":"2012","unstructured":"S\u00e1ez D, Fern\u00e1ndez P, Rivera A, Andrews E, O\u00f1ate A (2012) Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine 30(7):1283\u20131290","journal-title":"Vaccine"},{"issue":"2","key":"1638_CR26","first-page":"182","volume":"16","author":"A Sa\u011fmak Tartar","year":"2019","unstructured":"Sa\u011fmak Tartar A, Ozer Bal\u0131n \u015e, Akbulut A, Yard\u0131m M, Ayd\u0131n S (2019) Roles of dermcidin, salusin-\u03b1, salusin-\u03b2 and TNF-\u03b1 in the pathogenesis of human brucellosis. Iran J Immunol 16(2):182\u2013189","journal-title":"Iran J Immunol"},{"key":"1638_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12602-020-09684-1","volume":"13","author":"H Shirdast","year":"2021","unstructured":"Shirdast H, Ebrahimzadeh F, Taromchi AH, Mortazavi Y, Esmaeilzadeh A, Sekhavati MH, Nedaei K, Mirabzadeh E (2021) Recombinant Lactococcus lactis displaying Omp31 antigen of Brucella melitensis can induce an immunogenic response in BALB\/c mice. Probiotics Antimicrob Proteins 13:80\u201389","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"1638_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/17425247.2020.1731468","volume":"17","author":"M Skwarczynski","year":"2020","unstructured":"Skwarczynski M, Toth I (2020) Non-invasive mucosal vaccine delivery: advantages, challenges and the future. Expert Opin Drug Deliv 17(4):435\u2013437","journal-title":"Expert Opin Drug Deliv"},{"key":"1638_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imlet.2020.06.007","volume":"225","author":"J Song","year":"2020","unstructured":"Song J, Zhao L, Song M (2020) A Lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic Escherichia coli lethal challenge. Immunol Lett 225:57\u201363","journal-title":"Immunol Lett"},{"key":"1638_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2023.129387","volume":"385","author":"MP Soumya","year":"2023","unstructured":"Soumya MP, Parameswaran R, Nampoothiri KM (2023) Nisin controlled homologous over-expression of an exopolysaccharide biosynthetic glycosyltransferase gene for enhanced EPS production in Lactobacillus plantarum BR2. Bioresour Technol 385:129387","journal-title":"Bioresour Technol"},{"issue":"7","key":"1638_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202201008","volume":"20","author":"S Taghiloo","year":"2023","unstructured":"Taghiloo S, Ghajari G, Zand Z, Kabiri-Samani S, Kabiri H, Rajaei N, Piri-Gharaghie T (2023) Designing alginate\/chitosan nanoparticles containing Echinacea angustifolia: a novel candidate for combating multidrug-resistant Staphylococcus aureus. Chem Biodivers 20(7):e202201008","journal-title":"Chem Biodivers"},{"issue":"10","key":"1638_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1139\/W08-077","volume":"54","author":"J Villena","year":"2008","unstructured":"Villena J, Medina M, Raya R, Alvarez S (2008) Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Can J Microbiol 54(10):845\u2013853","journal-title":"Can J Microbiol"},{"issue":"4","key":"1638_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/713608012","volume":"29","author":"S Yingst","year":"2003","unstructured":"Yingst S, Hoover DL (2003) T cell immunity to brucellosis. Crit Rev Microbiol 29(4):313\u2013331","journal-title":"Crit Rev Microbiol"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01638-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-023-01638-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01638-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T15:08:02Z","timestamp":1704294482000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-023-01638-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1638"],"URL":"https:\/\/doi.org\/10.1186\/s13568-023-01638-4","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All persons who meet authorship criteria are listed as authors and all authors have seen and approved the final version of the manuscript begin submitted. Furthermore, all authors certify that they have participated sufficiently in the work to take public responsibility for the content including participation in the concept, design, analysis and writing. Finally, each author certify that the article is the authors\u2019 original work, and it hasn\u2019t received prior publication and isn\u2019t under consideration for publication elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this article declare their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}